scholarly journals Oncology Drug Shortages—What We Have Versus What We Expect to Have? A Critical Scenario of Pakistan

2018 ◽  
Vol 35 (1) ◽  
pp. 41-42 ◽  
Author(s):  
Ehsan Elahi ◽  
Sidrah Andleeb

Drug shortages in tertiary care hospitals always limit the health system’s ability to provide quality care to the patients. Immediately following the existing shortage of 5 different oncology drugs in Pakistan, numerous patients are finding themselves in a desperate state of no cure for their illness. Cardinal factors responsible for this unfortunate situation include interruption in vendor supplies and regulatory authorities’ issues related to approval and pricing. Effective review of policies by regulatory authorities for availability of drugs will certainly avoid this miserable condition in the future and ensure continuation of high-quality care to patients by health care systems.

2020 ◽  
Vol 11 (1) ◽  
pp. 44-56
Author(s):  
Gehan Abd Elfattah Elasrag ◽  
Hana Mohammad Abu-Snieneh

Safety and quality care of patients are key aspects and the mean goals of effective health care systems. The reality that medical treatment can harm patients is one that has had to be addressed by the healthcare community in recent years. This study aimed to explore nurses' perception of factors contributing to medication administration errors and reasons for which medication administration errors are not reporting. Descriptive exploratory cross-sectional design carried out to achieve the study aim. The study was conducted in two regional hospitals in Egypt. They had a total bed capacity of 512 beds distributed over three units (emergency, intensive care, and surgical units). A convenient sample of 146 nurses distributed in the morning and afternoon shifts in the units mentioned above was recruited in this study. Medication Administration Errors (MAEs) Reporting Scale used to collect data regarding the nurses' perception of factors contributing to the MAEs. The participants were ranked the most important factor for MAEs occur system reasons (24.73±1.46), followed by nurses staffing as the second reason of MAEs (24.11± 2.25). Third, fourth, and fifth-ranked reasons were physician communication (13.37± 2.7), medication packaging (12.84±1.87), transcription-related (8±0.1), respectively. Finally, pharmacy processes (6.9±2.93) viewed as the least factor for the frequency of MAE. The findings of the present study concluded seven perceived reasons for MAE, namely system reason, nurses' staffing, physician communication, medication packaging, transcription, and pharmacy process. The study recommended the development of active quality assurance systems in all health care environments concerning medications and drug administration.


Stroke ◽  
2017 ◽  
Vol 48 (suppl_1) ◽  
Author(s):  
Andrei V Alexandrov ◽  
Georgios Tsivgoulis ◽  
Katherine Nearing ◽  
Marc Malkoff ◽  
Odysseas Kargiotis ◽  
...  

Background: An increasing shortage of vascular neurologists forced an academic provider to find a city-wide solution to offer 24x7 access to intravenous thrombolysis (IVT) across independent and competing health care systems in the area. We sought to prospectively evaluate the annual IVT treatment delivery in our population and compare it to leading stroke centers worldwide. Methods: The largest single ER system and 3 other independent hospital providers in the area agreed to work with a single practice plan vascular neurology team (catchment area of 1,344,127 individuals). All acute ischemic stroke patients that were treated with IVT across all primary or tertiary care centers in our area were prospectively documented over a 12-month period (January-December 2015). A literature search was performed using narrative review methodology to document similar population-based treatment rates across leading stroke centers in North America, Europe and Australasia. Results: A total of 552 patients received IVT with tissue plasminogen activator (tPA) in 2015. Single ER system delivered 433 IV tPA treatments and 119 more patients were treated in the remaining hospitals. The annual tPA treatment rate was 41 per 100.000 individuals (95%CI: 38-44) favorably comparable to published annual treatment rates from leading international stroke centers (Table, 1998 thru 2015). Conclusions: A city-wide vascular neurology team can attend to patient populations across competing health care systems in the U.S. and deliver IVT at volumes and rates above those reported by leading treatment centers worldwide. Communities with competing systems can improve tPA delivery by sharing vascular neurology resources.


2017 ◽  
Vol 114 (43) ◽  
pp. 11368-11373 ◽  
Author(s):  
Leying Guan ◽  
Xiaoying Tian ◽  
Saurabh Gombar ◽  
Allison J. Zemek ◽  
Gomathi Krishnan ◽  
...  

Maintaining a robust blood product supply is an essential requirement to guarantee optimal patient care in modern health care systems. However, daily blood product use is difficult to anticipate. Platelet products are the most variable in daily usage, have short shelf lives, and are also the most expensive to produce, test, and store. Due to the combination of absolute need, uncertain daily demand, and short shelf life, platelet products are frequently wasted due to expiration. Our aim is to build and validate a statistical model to forecast future platelet demand and thereby reduce wastage. We have investigated platelet usage patterns at our institution, and specifically interrogated the relationship between platelet usage and aggregated hospital-wide patient data over a recent consecutive 29-mo period. Using a convex statistical formulation, we have found that platelet usage is highly dependent on weekday/weekend pattern, number of patients with various abnormal complete blood count measurements, and location-specific hospital census data. We incorporated these relationships in a mathematical model to guide collection and ordering strategy. This model minimizes waste due to expiration while avoiding shortages; the number of remaining platelet units at the end of any day stays above 10 in our model during the same period. Compared with historical expiration rates during the same period, our model reduces the expiration rate from 10.5 to 3.2%. Extrapolating our results to the ∼2 million units of platelets transfused annually within the United States, if implemented successfully, our model can potentially save ∼80 million dollars in health care costs.


2021 ◽  
Vol 2 ◽  
pp. 263348952110117
Author(s):  
Julie E Richards ◽  
Gregory E Simon ◽  
Jennifer M Boggs ◽  
Rinad Beidas ◽  
Bobbi Jo H Yarborough ◽  
...  

Background: Suicide rates continue to rise across the United States, galvanizing the need for increased suicide prevention and intervention efforts. The Zero Suicide (ZS) model was developed in response to this need and highlights four key clinical functions of high-quality health care for patients at risk of suicide. The goal of this quality improvement study was to understand how six large health care systems operationalized practices to support these functions—identification, engagement, treatment and care transitions. Methods: Using a key informant interview guide and data collection template, researchers who were embedded in each health care system cataloged and summarized current and future practices supporting ZS, including, (1) the function addressed; (2) a description of practice intent and mechanism of intervention; (3) the target patient population and service setting; (4) when/how the practice was (or will be) implemented; and (5) whether/how the practice was documented and/or measured. Normalization process theory (NPT), an implementation evaluation framework, was applied to help understand how ZS had been operationalized in routine clinical practices and, specifically, what ZS practices were described by key informants ( coherence), the current state of norms/conventions supporting these practices ( cognitive participation), how health care teams performed these practices ( collective action), and whether/how practices were measured when they occurred ( reflexive monitoring). Results: The most well-defined and consistently measured ZS practices (current and future) focused on the identification of patients at high risk of suicide. Stakeholders also described numerous engagement and treatment practices, and some practices intended to support care transitions. However, few engagement and transition practices were systematically measured, and few treatment practices were designed specifically for patients at risk of suicide. Conclusions: The findings from this study will support large-scale evaluation of the effectiveness of ZS implementation and inform recommendations for implementation of high-quality suicide-related care in health care systems nationwide. Plain Language Summary Many individuals see a health care provider prior to death by suicide, therefore health care organizations have an important role to play in suicide prevention. The Zero Suicide model is designed to address four key functions of high-quality care for patients at risk of suicide: (1) identification of suicide risk via routine screening/assessment practices, (2) engagement of patients at risk in care, (3) effective treatment, and (4) care transition support, particularly after hospitalizations for suicide attempts. Researchers embedded in six large health care systems, together caring for nearly 11.5 million patients, are evaluating the effectiveness of the Zero Suicide model for suicide prevention. This evaluation focused on understanding how these systems had implemented clinical practices supporting Zero Suicide. Researchers collected qualitative data from providers, administrators, and support staff in each system who were responsible for implementation of practices supporting Zero Suicide. Normalization process theory, an implementation evaluation framework, was applied following data collection to: (A) help researchers catalog all Zero Suicide practices described, (B) describe the norms/conventions supporting these practices, (C) describe how health care teams were performing these practices, and (D) describe how practices were being measured. The findings from this evaluation will be vital for measuring the effectiveness of different Zero Suicide practices. This work will also provide a blueprint to help health care leaders, providers, and other stakeholders “normalize” new and existing suicide prevention practices in their own organizations.


Author(s):  
Rajesh Kumar Bhola ◽  
B. B. Pradhan

An affordable health scheme has been always required by the Indian people. Even after passing74 years of Indian independence, quality healthcare has not been accessible to the Indian people. The data have shown out of the vast population of India only 25 percent of people are insured under the private and government insurance scheme. To overcome this problem Indian government has launched the Ayushman Bharat scheme on 25 December 2018 on the occasion of the birth anniversary of Pt. Deen Dayal Upadhyaya. The Ayushman Bharat is the Hindi translation of “India blessed with long life”. This scheme is the biggest health care scheme in the world which covers the huge population of India and the covered population under this scheme is more than 100 million. The scheme has categories into the primary, secondary, and tertiary care domain to address the health-related problems of the people and the most important and fascinating feature of the scheme is that a beneficiary avails the facilities in government hospital along with private hospitals. The present study reviews different aspects of the scheme in relevance to the helath sector to provide better perpective towards Indian health care systems.


2002 ◽  
Vol 37 (6) ◽  
pp. 668-671
Author(s):  
F. Randy Vogenberg

Managed health care has changed the way health services are provided and paid for. Many pharmacists have already felt the impact of these changes. This continuing feature illuminates the many facets of managed care, with a special emphasis on how these changes are affecting pharmacists working in health systems. Managed health care systems are still evolving, and the expertise of pharmacists will be needed for these systems to attain their primary goal: the delivery of affordable, comprehensive, high-quality health care.


2021 ◽  
Vol 22 (1) ◽  
Author(s):  
Timothy J. Steiner ◽  
Rigmor Jensen ◽  
Zaza Katsarava ◽  
Lars Jacob Stovner ◽  
Derya Uluduz ◽  
...  

AbstractIn countries where headache services exist at all, their focus is usually on specialist (tertiary) care. This is clinically and economically inappropriate: most headache disorders can effectively and more efficiently (and at lower cost) be treated in educationally supported primary care. At the same time, compartmentalizing divisions between primary, secondary and tertiary care in many health-care systems create multiple inefficiencies, confronting patients attempting to navigate these levels (the “patient journey”) with perplexing obstacles.High demand for headache care, estimated here in a needs-assessment exercise, is the biggest of the challenges to reform. It is also the principal reason why reform is necessary.The structured headache services model presented here by experts from all world regions on behalf of the Global Campaign against Headache is the suggested health-care solution to headache. It develops and refines previous proposals, responding to the challenge of high demand by basing headache services in primary care, with two supporting arguments. First, only primary care can deliver headache services equitably to the large numbers of people needing it. Second, with educational supports, they can do so effectively to most of these people. The model calls for vertical integration between care levels (primary, secondary and tertiary), and protection of the more advanced levels for the minority of patients who need them. At the same time, it is amenable to horizontal integration with other care services. It is adaptable according to the broader national or regional health services in which headache services should be embedded.It is, according to evidence and argument presented, an efficient and cost-effective model, but these are claims to be tested in formal economic analyses.


Sign in / Sign up

Export Citation Format

Share Document